Prof Jon Watson



Professor of Medicine


Faculty of Health


School of Medicine


Geelong Waurn Ponds Campus


Doctor of Philosophy, Univ. of Newcastle Upon Tyne, 2015
Master of Arts, University of Cambridge, 2015
Bachelor of Medicine, University of Oxford, 2015
Bachelor of Surgery, University of Oxford, 2015
Fellow of Royal Australasian College of Physicians, Royal Aust. Coll.of Physicians, 2015

+61 3 522 71275


Professor Jon Watson is Head of the School of Medicine at Deakin University.


Prof Watson was educated in the UK, and then attended Cambridge University for his undergraduate degree in medicine, and Oxford University for his clinical studies. After House Jobs in Oxford and Bath, he went to London for a year (Hammersmith and Queen Square Hospitals), before moving to Newcastle upon Tyne in the North East of England for his specialist training in Gastroenterology, Hepatology and General Medicine. Whilst working in Newcastle upon Tyne he was awarded a PhD for studies into liver disease.


He migrated to Australia in 1997 with his family. Since then, he has worked in Ballarat, Stawell, Newcastle NSW, and now Geelong. He also has clinical appointments at University Hospital Geelong, Geelong Private Hospital, St John of God Hospital (Geelong and Ballarat), the Ballarat Day Procedure Centre, and Stawell Hospital.


Prof Watson has maintained an active research interest in Hepatitis C Virus (HCV) related liver disease having published on HCV in peer reviewed journals, and presented on HCV at national and international meetings for the last 20 years, and has been Meeting Organiser (twice) for the Australian Gastroenterology Society's annual meeting. He is also a member of the National Examining Panel of the Royal Australasian College of Physicians.


Prof Watson is a Fellow of the Royal College of Physicians of London and a Fellow of the Royal Australasian College of Physicians. He is fully accredited in Endoscopy (Gastroscopy, Colonoscopy, ERCP and Capsule Endoscopy) and has Specialist Recognition by the Australian Medical Board to practice in Gastroenterology, Hepatology and General Medicine.

Read more on Jon's profile

Biography summary

Professor Jon Watson is Head of the School of Medicine at Deakin University


Filter by


Leasing a medical curriculum: what's it worth?

David Prideaux, Julie Ash, Simon Broadley, Brendan Crotty, William Hart, Judy Searle, Jon Watson, Lindon Wing, Paul Worley

(2019), Vol. 41, pp. 697-702, Medical teacher, London, Eng., C1


Neocarzinostatin, aptamer conjugates for targeting EpCAM-positive tumor cells

P Athyala, J Kanwar, S Chitipothu, R Kanwar, S Krishnakumar, J Watson, J Narayanan

(2017), Vol. 37, pp. 3615-3629, Anticancer research, Kapandriti Attica, Greece, C1


Cohort analysis of simulation-based medical training for decision support

J Zhang, S Hanoun, B Khan, D Creighton, S Nahavandi, K Britt, K D'Souza, J Watson, R Yanieri

(2017), pp. 2608-2612, SMC 2017 : Proceedings of the IEEE International Conference on Systems, Man, and Cybernetics, Banff, Canada, E1


Probing the biophysical interaction between Neocarzinostatin toxin and EpCAM RNA aptamer

P Athyala, J Kanwar, M Alameen, R Kanwar, S Krishnakumar, J Watson, U Vetrivel, J Narayanan

(2016), Vol. 469, pp. 257-262, Biochemical and biophysical research communications, Amsterdam, The Netherlands, C1


Nurse-led clinic: effective and efficient delivery of assessment and review of patients with hepatitis B and C

M Biddle, N Adler, S Heath, S Streat, M Wardrop, J Watson

(2014), Vol. 44, pp. 581-585, Internal Medicine Journal, Richmond, Vic., C1


Hepatitis C virus treatment in the 'real-world': how well do 'real' patients respond?

N Friedman, J Green, H Weber, S Stephen, S Lane, A Ting, J Watson

(2014), Vol. 4, pp. 214-220, Journal of clinical and experimental hepatology, Gurgaon, India, C1


Distribution of interferon lambda-3 gene polymorphisms in Australian patients with previously untreated genotype 1 chronic hepatitis C: analysis from the PREDICT and CHARIOT studies

Stuart Roberts, Joanne Mitchell, Reynold Leung, David Booth, Steven Bollipo, George Ostapowicz, Andrew Sloss, Geoffrey McCaughan, Gregory Dore, Alexander Thompson, Darrell Crawford, William Sievert, Martin Weltman, Wendy Cheng, Jacob George, Australian Liver Association Clinical Research Net, Johnathan Watson

(2014), Vol. 29, pp. 179-184, Journal of gastroenterology and hepatology, Chichester, Eng., C1


Chronic hepatitis C

J Watson, C Hair

(2008), Vol. 9, pp. 66-67, Medicine Today, C1-1


The tissue effect of argon plasma coagulation on esophageal and gastric mucosa

J Watson, M Bennett, S Griffin, K Matthewson

(2000), Vol. 52, pp. 342-345, Gastrointestinal endoscopy, Amsterdam, The Netherlands, C1-1


Case report: oral antioxidant therapy for the treatment of primary biliary cirrhosis: a pilot study

J Watson, D Jones, O James, P Cann, M Bramble

(1999), Vol. 14, pp. 1034-1040, Journal of gastroenterology and hepatology, Chichester, Eng., C1-1


Massively elevated serum ferritin in an ill man with abnormal liver function tests

J Watson, M Bramble, S Ghosh

(1998), Vol. 74, pp. 619-620, Postgraduate medical journal, London, Eng., C1-1


Percutaneous endoscopic gastroenterostomy and jejunal extension for gastric stasis in pancreatic carcinoma

J Watson, K Mannix, K Matthewson

(1997), Vol. 11, pp. 407-410, Palliative medicine, London, Eng., C1-1


Hepatitis C virus: Epidemiology and genotypes in the north east of England

J Watson, A Brind, C Chapman, C Bates, F Gould, S Johnson, A Burt, J Ferguson, P Simmonds, M Bassendine

(1996), Vol. 38, pp. 269-276, Gut, C1-1


Hepatitis C virus infection in the elderly

A Brind, J Watson, O James, M Bassendine

(1996), Vol. 89, pp. 291-296, QJM: an international journal of medicine, Oxford, Eng., C1-1


Non-Hodgkin's lymphoma and hepatitis C virus infection

A Brind, J Watson, A Burt, P Kestevan, J Wallis, S Proctor, M Bassendine

(1996), Vol. 21, pp. 127-130, Leukemia and lymphoma, Abingdon, Eng., C1-1


Hepatitis C virus density heterogeneity and viral titre in acute and chronic infection: a comparison of immunodeficient and immunocompetent patients

J Watson, D Bevitt, G Spickett, G Toms, M Bassendine

(1996), Vol. 25, pp. 599-607, Journal of hepatology, Amsterdam, The Netherlands, C1-1


Ribavirin treatment for patients with chronic hepatitis C: results of a placebo-controlled study

G Dusheiko, J Main, H Thomas, O Reichard, C Lee, A Dhillon, S Rassam, A Fryden, H Reesink, M Bassendine, G Norkrans, T Cuypers, N Lelie, P Telfer, J Watson, C Weegink, P Sillikens, O Weiland

(1996), Vol. 25, pp. 591-598, Journal of hepatology, Amsterdam, The Netherlands, C1-1


Prokaryotic expression and analysis of the antibody response to a Newcastle isolate of the core gene of hepatitis C

I Milton, M Carter, G Toms, J Watson, M Bassendine, K Quo

(1995), Vol. 45, pp. 253-258, Journal of medical virology, Chichester, Eng., C1-1


Funded Projects at Deakin

Industry and Other Funding

Support Funding Appointment for to Head of Research at OrthoSport Victoria Research Unit.

Prof Jon Watson

  • 2018: $155,000
  • 2017: $150,000
  • 2016: $100,000
  • 2015: $100,000
  • 2014: $100,000
  • 2013: $50,000


Associate Supervisor

Prasanna Kumar Athyala

Thesis entitled: Oligonucleotide-Conjugates for Targeting EpCAM Positive Tumor Cells

Doctor of Philosophy (Medicine), School of Medicine